What’s New November/December 2021

Published on 12/21/2021

5 min read

Newsletter updates for November/December 2021
Dec/Nov News from SOPHiA GENETICS

alt_text

Newsletter – December/November 2021

DEEP-Lung-IV Multimodal Clinical Study

Our new study leverages deep learning-enabled analysis of the aggregation of multimodal clinical, biological, genomic, and radiomics data to identify and validate predictive signatures associated with response to immunotherapy and prognosis of patients with metastatic non-small cell lung cancer (NSCLC).

2021 Milestones – End of year recap

Hear from our CEO Jurgi Camblong as he recaps a major year for SOPHiA GENETICS. We're topping off a decade of Data Driven Medicine and looking toward the new year with determination.

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

We officially announced our collaboration with GE at RSNA where we co-hosted a comprehensive symposium about the role of the Radiologist and their use of emerging clinical technology as part of the healthcare revolution.

Radiomics: 5 Things You Need to Know

Ahead of RSNA we prepared an introductory list and explanation of 5 things we think you should know about implementing Radiomics.

Upcoming events


PMWC – Silicon Valley
January 26, 2022 – January 28, 2022
In-person


Festival of Genomics
January 27, 2022 – January 28, 2022
Virtual


Scope 2022
February 7, 2022 – February 10, 2022
In-person, Virtual

In The News


Boston Globe

Open and transparent science could lead to unprecedented progress
 

The Straits Times

What we know about Omicron, the Covid-19 variant that has sparked global alarm

Boston Globe

Ushering in open science: Will COVID-19 forever change research and development?

arrow arrow arrow arrow arrow

DISCLAIMER

The information included in this document has been prepared for and is intended for viewing by a global audience. This document contains information about products and services which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indication for use. Please consult local sales representative.

 

alt_text

pink dots icon

Related Posts

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.